BVEIX | VIVIX | BVEIX / VIVIX | |
Total Expense Ratio | 0.68 | 0.04 | 1,700% |
Annual Report Gross Expense Ratio | 0.94 | 0.04 | 2,350% |
Fund Existence | 14 years | 27 years | - |
Gain YTD | 9.055 | 6.533 | 139% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 5000000 | 2% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 97.1M | 196B | 0% |
Annual Yield % from dividends | 1.15 | 2.19 | 53% |
Returns for 1 year | 7.55 | 7.91 | 96% |
Returns for 3 years | 7.77 | 25.93 | 30% |
Returns for 5 years | 35.37 | 68.54 | 52% |
Returns for 10 years | 33.82 | 114.61 | 30% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYAEX | 120.87 | 0.70 | +0.58% |
Rydex Europe 1.25x Strategy A | |||
GLCGX | 33.58 | -0.02 | -0.06% |
Goldman Sachs Large Cap Gr Insghts A | |||
MGOCX | 33.90 | -0.08 | -0.24% |
NYLI WMC Enduring Capital Class C | |||
HCAFX | 45.30 | -0.12 | -0.26% |
Hartford Capital Appreciation F | |||
HDSIX | 22.91 | -0.10 | -0.43% |
Hodges Small Cap Grwoth Institutional |